Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress Disorder

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Hauer, Daniela ^a   Schelling, Gustav ^a   Gola, Hannah ^b,d   Campolongo, Patrizia ^c   Morath, Julia ^d   Roozendaal, Benno ^e   Hamuni, Gilava ^b,d   Karabatsiakis, Alexander ^b   Atsak, Piray ^e   Vogeser, Michael ^a   Kolassa, Iris Tatjana ^b,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF KONSTANZ   (Germany)

^e RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; ENDOCANNABINOID; HYDROCORTISONE; N ACYLETHANOLAMIDE; N OLEOYLDOPAMINE; N OLEOYLETHANOLAMINE; PALMIDROL; STEAROYLETHANOLAMINE; UNCLASSIFIED DRUG;

2 ARACHIDONOYLGLYCEROL BLOOD LEVEL; ADULT; ANANDAMIDE BLOOD LEVEL; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; BLOOD LEVEL; CLINICAL ARTICLE; CLINICIAN ADMINISTERED POST TRAUMATIC STRESS DISORDER SCALE; CONTROLLED STUDY; ENDOCANNABINOID BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; MASS SPECTROMETRY; MOLECULAR PATHOLOGY; N ACYLETHANOLAMIDE BLOOD LEVEL; N OLEOYLDOPAMINE BLOOD LEVEL; N OLEOYLETHANOLAMINE BLOOD LEVEL; PALMIDROL BLOOD LEVEL; POSTTRAUMATIC STRESS DISORDER; PROTEIN FUNCTION; SCORING SYSTEM; STEAROYLETHANOLAMINE BLOOD LEVEL;

ADULT; AMIDES; CASE-CONTROL STUDIES; COHORT STUDIES; ENDOCANNABINOIDS; FEMALE; HUMANS; HYDROCORTISONE; MALE; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; TORTURE; WAR;

EID: 84877149994     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062741     Document Type: Article

References (46)

1. De Petrocellis L, Cascio MG, Di Marzo V, (2004) The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141: 765-774.
2. Pacher P, Steffens S, (2009) The emerging role of the endocannabinoid system in cardiovascular disease. Semin Immunopathol 31: 63-77.
3. Di FM, Pini LA, Pelliccioli GP, Calabresi P, Sarchielli P, (2008) Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. J Neurol Neurosurg Psychiatry 79: 1224-1229.
4. Jean-Gilles L, Gran B, Constantinescu CS, (2010) Interaction between cytokines, cannabinoids and the nervous system. Immunobiology 215: 606-610.
5. Despres JP, Golay A, Sjostrom L, (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353: 2121-2134.
6. Grimaldi C, Capasso A, (2011) The endocannabinoid system in the cancer therapy: an overview. Curr Med Chem 18: 1575-1583.
7. Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ, (2009) Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34: 1257-1268.
8. Schwarz E, Whitfield P, Nahnsen S, Wang L, Major H, et al. (2011) Alterations of primary fatty acid amides in serum of patients with severe mental illness. Frontiers in Bioscience 3: 308-314.
9. Patel S, Hillard CJ, (2008) Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 27: 2821-2829.
10. Chouker A, Kaufmann I, Kreth S, Hauer D, Feuerecker M, et al. (2010) Motion sickness, stress and the endocannabinoid system. PLoS One 5: e10752.
11. Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, et al. (2010) Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci U S A 107: 9406-9411.
12. Moreira FA, Wotjak CT, (2010) Cannabinoids and anxiety. Current Topics in Behavioral Neurosciences 2: 429-450.
13. Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, et al. (2009) Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A 106: 4888-4893.
14. Atsak P, Hauer D, Campolongo P, Schelling G, McGaugh JL, et al. (2012) Glucocorticoids interact with the hippocamapal endocannabinoid system in impairing retrieval of contextual fear memory. Proc Natl Acad Sci U S A 109: 3504-3509.
15. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, et al. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.
16. Cornelius JR, Kirisci L, Reynolds M, Clark DB, Hayes J, et al. (2010) PTSD contributes to teen and young adult cannabis use disorders. Addictive Behaviors 35: 91-94.
17. Fraser GA, (2009) The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS neuroscience & therapeutics 15: 84-88.
18. Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ, (2008) Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 41: 48-53.
19. Hauer D, Weis F, Campolongo P, Azad S, Schelling G, (2008) Traumatic Memories in Surgical Patients Are a Significant Predictor of Endocannabinoid Activity. Anesthesiology 109: A1015.
20. Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, et al. (2009) Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation 119: 28-36.
21. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, et al. (1995) The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8: 75-90.
22. Cote M, Matias I, Lemieux I, Petrosino S, Almeras N, et al. (2007) Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond) 31: 692-699.
23. Rief W, Hiller W, (2003) A new approach to the assessment of the treatment effects of somatoform disorders. Psychosomatics 44: 492-498.
24. Schauer M, Neuner F, Elbert T (2011): Vivo Checklist for War, Detention, and Torture Events; in: Narrative Exposure Therapy (NET). A Short-Term Intervention for Traumatic Stress Disorders. Cambridge/Göttingen, Hogrefe & Huber Publishers, 77-79.
25. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59Suppl 20: 22-33.
26. Hamilton M, (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
27. Stoll C, Kapfhammer HP, Rothenhausler HB, Haller M, Briegel J, et al. (1999) Sensitivity and specificity of a screening test to document traumatic experiences and to diagnose post-traumatic stress disorder in ARDS patients after intensive care treatment. Intensive Care Med 25: 697-704.
28. Balvers MG, Verhoeckx KC, Witkamp RF, (2009) Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877: 1583-1590.
29. Fanelli F, Di Lallo VD, Belluomo I, De Iasio R, Baccini M, et al. (2011) Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimension-LC/MS/MS. J Lipid Res 53: 481-493.
30. Dlugos A, Childs E, Stuhr KL, Hillard CJ, de Wit H, (2012) Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology 37: 2416-2427.
31. Kulisch C, Albrecht D, (2013) Effects of single swim stress on changes in TRPV1-mediated plasticity in the amygdala. Behav Brain Res 236: 344-349.
32. Maccarrone M, Cartoni A, Parolaro D, Margonelli A, Massi P, et al. (2002) Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system. Mol Cell Neurosci 21: 126-140.
33. Vogeser M, Hauer D, Christina Azad S, Huber E, Storr M, et al. (2006) Release of anandamide from blood cells. Clin Chem Lab Med 44: 488-491.
34. Schmidt A, Brune K, Hinz B, (2006) Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. Biomed Chromatogr 20: 336-342.
35. Di Marzo V, Verrijken A, Hakkarainen A, Petrosino S, Mertens I, et al. (2009) Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. Eur J Endocrinol 161: 715-722.
36. Vogeser M, Schelling G, (2007) Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples. Clin Chem Lab Med 45: 1023-1025.
37. Feuerecker M, Hauer D, Toth M, Demetz F, Hölzl J, et al. (2012) Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur J Appl Physiol 112: 2777-2781.
38. Heyman E, Gamelin FX, Goekint M, Piscitelli F, Roelands B, et al. (2011) Intense exercise increases circulating endocannabinoid and BDNF levels in humans-Possible implications for reward and depression. Psychoneuroendocrinology 37: 844-851.
39. Hauer D, Weis F, Campolongo P, Schopp M, Beiras-Fernandez A, et al. (2012) Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression. Rev Neurosci 23: 681-690.
40. Ganon-Elazar E, Akirav I, (2012) Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress. Neuropsychopharmacology 37: 456-466.
41. Weis F, Beiras-Fernandez A, Hauer D, Hornuss C, Sodian R, et al. (2010) Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery. British Journal of Anaesthesia 105: 139-144.
42. Centonze D, Battistini L, Maccarrone M, (2008) The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Curr Pharm Des 14: 2370-2342.
43. Boscarino JA, (2008) A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: implications for surveillance and prevention. Psychosom Med 70: 668-676.
44. Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, et al. (2009) Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 34: 2733-2745.
45. Glaser ST, Gatley SJ, Gifford AN, (2006) Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. J Pharmacol Exp Ther 316: 1088-1097.
46. Campolongo P, Roozendaal B, Trezza V, Cuomo V, Astarita G, et al. (2009) Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proc Natl Acad Sci U S A 106: 8027-8031.